Profectus Biosciences
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Profectus Biosciences - overview
Established
2003
Location
Baltimore, MD, US
Primary Industry
Pharmaceuticals
About
Profectus Biosciences, is based in Baltimore, US and is a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases with a goal of reducing morbidity and mortality.
Current Investors
Cross Atlantic Capital Partners, PATH Malaria Vaccine Initiative, National Institute of Allergy and Infectious Diseases
Primary Industry
Pharmaceuticals
Sub Industries
Biotechnology, Epidemiology, Diagnostic, Medical & Imaging Laboratories, Pharmaceutical Research & Development
Website
profectusbiosciences.com
Company Stage
Series C
Total Amount Raised
Subscriber access only
Profectus Biosciences - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| President & CEO, Board Director | BM | ||||||
| President & CEO, Board Director | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.